Stocks
Dicerna Pharmaceuticals (DRNA) ROE US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -144.4% | -59.3% | -44.3% | -79.1% | -81.8% | -115.6% | ||
| Changes by years, y/y, % | -75pp | +85pp | +15pp | -35pp | -3pp | +3.5% | |||
Dicerna Pharmaceuticals. ROE, %
Dicerna Pharmaceuticals. ROE, changes, pp
Dicerna Pharmaceuticals (DRNA) ROE US GAAP (quarter values) |
||||||||
| 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | LTM ? | |||
| ROE, % | ? | -75.4% | -81.8% | -95.1% | -116.3% | -115.6% | -115.6% | |
| Changes by years, y/y, % | -1pp | -3pp | -29pp | -39pp | -40pp | |||
| Changes by quarters, q/q, % | +2pp | -6pp | -13pp | -21pp | +1pp | |||
